Article - Page 5 of 8 - Echosens

Choose your location

Choose your language

FibroScan^® 630 Expert: Complete, Non-invasive Solution Offers Effective Management and Risk Stratification for Patients with Cirrhosis and Portal Hypertension

Diabetes Wake-Up Call: Liver Screening Tools Help Battle Obesity-Related Diseases

Fatty Liver Disease Impacts Minority Populations: April 2021 is National Minority Health Month

COVID-19 Impact: Higher Risks of Severity Among Obese and Chronic Liver Disease Patients

FibroScan^® Recommended for Hepatitis C Patients

Understanding the Link Between Cardiovascular Disease and Liver Disease

Echosens Observes National Drug and Alcohol Facts Week 2021

Better Health for the Long Haul: Echosens and Healthy Trucking of America Collaborate

Noninvasive Tests Cost-Effectively Identify Patients at Risk for Liver Disease

Echosens Featured in OncologyTube

Précédent
1
2
3
4
5
6
7
8
Suivant

Country*
Your email address**
By subscribing, I agree that Echosens collects and uses my data in accordance with the Privacy Policy.
Comments
This field is for validation purposes and should be left unchanged.